Cure - Immualpha Inj. (Thymosin Alpha 1)

Components

Lyophilized Thymosin alpha 1 per vial and sterile water

Effects

Supplemental treatment for influenza vaccination in elderly patients with impaired immune functions.

Usage/Dosage

900µg/m² (1 vial) is intended for subcutaneous or intramuscular injection twice a week for 4 weeks after vaccination.

It should be reconstituted with 1.0 ml of sterile water provided for injection, immediately prior to use.

Package

1 vial (Diluent) X 2

Storage

Sealed container, between 2°and 8°C, keep out of direct sunlight.